On April 17, 2024, Exact Sciences Corporation closed the transaction. The company issued 1.75% Senior Unsecured Convertible Notes due April 15, 2031 for a principal amount of $266,750,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.88 USD | -2.04% |
|
-2.45% | -43.39% |
Jun. 11 | Exact Sciences Seeks Acquisitions | CI |
Jun. 11 | Transcript : Exact Sciences Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 03:20 PM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.39% | 7.73B | |
+11.68% | 3.7B | |
+0.37% | 2.28B | |
-21.21% | 1.99B | |
-23.77% | 1.6B | |
+18.25% | 739M | |
-10.04% | 687M | |
-36.12% | 461M | |
-4.47% | 279M | |
-16.34% | 160M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Exact Sciences Corporation announced that it has received $266.75 million in funding